جدول الترويج Apollomics, Inc.
الجدول الزمني المتقدم
رسم بياني بسيط
عن الشركة
Apollomics, Inc., a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways. Its solutions include tumor inhibitors, anti-cancer enhancers, and immune-oncology drugs. Apollomics, Inc. مزيد من التفاصيل| EBITDA | -0.0742 |
|---|---|
| EV/EBITDA | 1.76 |
| IPO date | 2021-11-26 |
| Industry | Biotechnology |
| P/BV | 0.0543 |
| P/S | 2.27 |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Выручка | 0.0018 |
| Цена ао | 0.026 |
| Число акций ао | 0.0895 млрд |
| تغير السعر يوميا: | -0% (0.0122) |
|---|---|
| تغير السعر في الأسبوع: | -53.08% (0.026) |
| تغير السعر شهريا: | +41.86% (0.0086) |
| تغير السعر خلال 3 أشهر: | -53.08% (0.026) |
| تغير السعر على مدى ستة أشهر: | -53.08% (0.026) |
| تغير السعر سنويا: | -75.6% (0.05) |
| تغير الأسعار منذ بداية العام: | -39% (0.02) |
|
|
الاستهانة
|
كفاءة
|
|||||||||||||||||||||||||||||||||||||
توزيعات الأرباح
|
واجب
|
دافع النمو
|
|||||||||||||||||||||||||||||||||||||
| المؤسسات | مقدار | يشارك, % |
|---|---|---|
| Ehp Funds Inc. | 498450 | 4.82 |
| Warberg Asset Management LLC | 445600 | 4.31 |
| Walleye Capital LLC | 383744 | 3.71 |
| BOOTHBAY FUND MANAGEMENT, LLC | 373715 | 3.61 |
| Yakira Capital Management, Inc. | 362364 | 3.5 |
| Shaw D.E. & Co., Inc. | 318530 | 3.08 |
| Context Capital Management, LLC | 298500 | 2.88 |
| MMCAP International, Inc. SPC | 250000 | 2.42 |
| Walleye Trading LLC | 215856 | 2.09 |
| Whitebox Advisors, LLC | 200000 | 1.93 |
